Ocular surface disturbance in patients after acute COVID-19.

Kelvin H WanGrace C Y LuiKen C F PoonSusanna S S NgAlvin L YoungDavid S C HuiClement C Y ThamPaul K S ChanChi Pui PangKelvin Kam-Lung Chong

Published in: Clinical & experimental ophthalmology (2022)

MGD and ocular surface staining are more common and severe in post-COVID-19 patients. Patients with higher viral loads have greater risks of ocular surface symptoms. Patients requiring supplementary oxygen are more likely to show tear film instability. Ocular surface evaluation should be considered 1-3 months following hospital discharge for any COVID-19 patient.

Keyphrases

sars cov
end stage renal disease
coronavirus disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
depressive symptoms
reduced graphene oxide
sleep quality
room temperature